Arkolith/Insider Trading/XERS/Form 4

McCulloch Kevin

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Feb 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2026Tax withholding(F)30K$7.36$223K1.8M
Jan 31, 2026Tax withholding(F)68K$7.36$504K1.8M
Jan 31, 2026Tax withholding(F)27K$7.36$201K1.7M
Jan 30, 2026Grant(A)168K—$01.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2026Grant(A)225K—$0225K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002031695-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Xeris Biopharma Holdings, Inc.

Build

Ask your agent about XERS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002031695-26-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Xeris Biopharma Holdings, Inc.
over the last 90 days and cite the filings.